Skip Nav Destination
Antibiotics and Chemotherapy
Pseudomonas aeruginosa in Human Diseases: 3rd International Symposium of Basic Research and Clinical Aspects of Pseudomonas aeruginosa Infection, Tokyo, September 1990
Edited by
S.Karger AG
Volume
44
Status:
Available
ISBN electronic:
978-3-318-03219-2
ISBN print:
978-3-8055-5385-8
Discontinued Book Series:
Antibiotics and Chemotherapy
Published online:
2015
Published in print:
1991
Pseudomonas aeruginosa in Human Diseases: 3rd International Symposium of Basic Research and Clinical Aspects of Pseudomonas aeruginosa Infection, Tokyo, September 1990
Edited by: J.Y. Homma, H. Tanimoto, I.A. Holder, N. Hoiby, G. Döring
https://doi.org/10.1159/isbn.978-3-318-03219-2
ISBN (print): 978-3-8055-5385-8
ISBN (electronic): 978-3-318-03219-2
Publisher: S.Karger AG
Published: 1991
Download citation file:
Digital Version
Pay-Per-View Access
$256.00
Print Version
Pseudomonas aeruginosa in Human Diseases
$256.00
Table of Contents
-
1 - 7: Whole DNA Genome TypingByUte Römling;Ute RömlingAbteilung Biophysikalische Chemie, Medizinische Hochschule, Hannover, FRGSearch for other works by this author on:Dietmar Grothues;Dietmar GrothuesAbteilung Biophysikalische Chemie, Medizinische Hochschule, Hannover, FRGSearch for other works by this author on:Burkhard TümmlerBurkhard TümmlerAbteilung Biophysikalische Chemie, Medizinische Hochschule, Hannover, FRGSearch for other works by this author on:
-
8 - 12: Cross-Colonization and Routes of Infection Assessed with a DNA ProbeByKonrad Botzenhart;Konrad BotzenhartDepartment of General and Environmental Hygiene, Hygiene Institute, University of Tübingen, FRGSearch for other works by this author on:Christiane Wolz;Christiane WolzDepartment of General and Environmental Hygiene, Hygiene Institute, University of Tübingen, FRGSearch for other works by this author on:Gerd DöringGerd DöringDepartment of General and Environmental Hygiene, Hygiene Institute, University of Tübingen, FRGSearch for other works by this author on:
-
13 - 22: Comparison of Different Typing Methods of Pseudomonas aeruginosaByB. Ojeniyi;B. OjeniyiUniversity of Copenhagen and Statens Seruminstitut’s Department of Clinical Microbiology and Staphylococcus Laboratory, and Pediatric Department G, Rigshospitalet, Copenhagen, DenmarkSearch for other works by this author on:N. HøibyN. HøibyUniversity of Copenhagen and Statens Seruminstitut’s Department of Clinical Microbiology and Staphylococcus Laboratory, and Pediatric Department G, Rigshospitalet, Copenhagen, DenmarkSearch for other works by this author on:
-
23 - 28: Chromosome Organization in Pseudomonas aeruginosa1ByB. W. Holloway;B. W. HollowayDepartment of Genetics and Developmental Biology, Monash University, Clayton, Vic, AustraliaSearch for other works by this author on:S. Dharmsthiti;S. DharmsthitiDepartment of Genetics and Developmental Biology, Monash University, Clayton, Vic, AustraliaSearch for other works by this author on:V. Krishnapillai;V. KrishnapillaiDepartment of Genetics and Developmental Biology, Monash University, Clayton, Vic, AustraliaSearch for other works by this author on:A. F. Morgan;A. F. MorganDepartment of Genetics and Developmental Biology, Monash University, Clayton, Vic, AustraliaSearch for other works by this author on:E. Ratnaningsih;E. RatnaningsihDepartment of Genetics and Developmental Biology, Monash University, Clayton, Vic, AustraliaSearch for other works by this author on:M. I. Sinclair;M. I. SinclairDepartment of Genetics and Developmental Biology, Monash University, Clayton, Vic, AustraliaSearch for other works by this author on:R. SafferyR. SafferyDepartment of Genetics and Developmental Biology, Monash University, Clayton, Vic, AustraliaSearch for other works by this author on:
-
29 - 33: Porins in the Outer Membrane of Pseudomonas aeruginosaByT. Nakae;T. NakaeDepartment of Cellular Information Sciences, Tokai University School of Medicine, Isehara, JapanSearch for other works by this author on:E. YoshiharaE. YoshiharaDepartment of Cellular Information Sciences, Tokai University School of Medicine, Isehara, JapanSearch for other works by this author on:
-
34 - 47: Phospholipase C: Molecular Biology and Contribution to the Pathogenesis of Pseudomonas aeruginosa1ByMichael L. Vasil;Michael L. VasilaDepartment of Microbiology and Immunology andSearch for other works by this author on:Le Roy M. Graham;Le Roy M. GrahambCardiovascular Pulmonary Research Laboratory, University of Colorado Health Sciences Center, Denver, Colo., USASearch for other works by this author on:Rachel M. Ostroff;Rachel M. OstroffaDepartment of Microbiology and Immunology andSearch for other works by this author on:Virginia D. Shortridge;Virginia D. ShortridgeaDepartment of Microbiology and Immunology andSearch for other works by this author on:Adriana I. VasilAdriana I. VasilaDepartment of Microbiology and Immunology andSearch for other works by this author on:
-
48 - 53: Molecular Approach to Pseudomonas aeruginosa Cytotoxin: Structure, Activation Mechanism and Phage ConversionByTetsuya Hayashi;Tetsuya HayashiDepartment of Bacteriology, Shinshu University School of Medicine, Matsumoto, JapanSearch for other works by this author on:Yoshiro TerawakiYoshiro TerawakiDepartment of Bacteriology, Shinshu University School of Medicine, Matsumoto, JapanSearch for other works by this author on:
-
54 - 58: Pore-Forming Cytotoxin of Pseudomonas aeruginosa: The Molecular Effects and Aspects of PathogenicityByF. Lutz;F. LutzInstitut für Pharmakologie und Toxikologie der Universität, Giessen, FRGSearch for other works by this author on:G. Xiong;G. XiongInstitut für Pharmakologie und Toxikologie der Universität, Giessen, FRGSearch for other works by this author on:R. Jungblut;R. JungblutInstitut für Pharmakologie und Toxikologie der Universität, Giessen, FRGSearch for other works by this author on:G. Orlik-Eisel;G. Orlik-EiselInstitut für Pharmakologie und Toxikologie der Universität, Giessen, FRGSearch for other works by this author on:A. Göbel-Reifert;A. Göbel-ReifertInstitut für Pharmakologie und Toxikologie der Universität, Giessen, FRGSearch for other works by this author on:R. LeidolfR. LeidolfInstitut für Pharmakologie und Toxikologie der Universität, Giessen, FRGSearch for other works by this author on:
-
59 - 62: ADP-Ribosylation and Activation of Phosphatidylinositol-Specific Phospholipase C by Pseudomonal LeukocidinByMasatoshi Noda;Masatoshi NodaaChiba University School of Medicine, Chiba, andSearch for other works by this author on:Iwao Kato;Iwao KatoaChiba University School of Medicine, Chiba, andSearch for other works by this author on:Xia Wang;Xia WangaChiba University School of Medicine, Chiba, andSearch for other works by this author on:Toshiya HirayamaToshiya HirayamabInstitute of Medical Science, University of Tokyo, JapanSearch for other works by this author on:
-
63 - 67: Pseudomonas aeruginosa Infection in Cystic Fibrosis: Biosynthesis of Alginate as a Virulence FactorByS. Roychoudhury;S. RoychoudhuryDepartment of Microbiology and Immunology, University of Illinois, College of Medicine, Chicago, Ill., USASearch for other works by this author on:N. A. Zielinski;N. A. ZielinskiDepartment of Microbiology and Immunology, University of Illinois, College of Medicine, Chicago, Ill., USASearch for other works by this author on:J. D. De Vault;J. D. De VaultDepartment of Microbiology and Immunology, University of Illinois, College of Medicine, Chicago, Ill., USASearch for other works by this author on:J. Kato;J. KatoDepartment of Microbiology and Immunology, University of Illinois, College of Medicine, Chicago, Ill., USASearch for other works by this author on:D. L. Shinabarger;D. L. ShinabargerDepartment of Microbiology and Immunology, University of Illinois, College of Medicine, Chicago, Ill., USASearch for other works by this author on:T. B. May;T. B. MayDepartment of Microbiology and Immunology, University of Illinois, College of Medicine, Chicago, Ill., USASearch for other works by this author on:R. Maharaj;R. MaharajDepartment of Microbiology and Immunology, University of Illinois, College of Medicine, Chicago, Ill., USASearch for other works by this author on:K. Kimbara;K. KimbaraDepartment of Microbiology and Immunology, University of Illinois, College of Medicine, Chicago, Ill., USASearch for other works by this author on:T. K. Misra;T. K. MisraDepartment of Microbiology and Immunology, University of Illinois, College of Medicine, Chicago, Ill., USASearch for other works by this author on:A. M. ChakrahartyA. M. ChakrahartyDepartment of Microbiology and Immunology, University of Illinois, College of Medicine, Chicago, Ill., USASearch for other works by this author on:
-
68 - 79: Alginate in InfectionBySvend Stenvang Pedersen;Svend Stenvang PedersenStatens Seruminstitut, Department of Clinical Microbiology at Rigshospitalet, Copenhagen, DenmarkSearch for other works by this author on:Niels Høiby;Niels HøibyStatens Seruminstitut, Department of Clinical Microbiology at Rigshospitalet, Copenhagen, DenmarkSearch for other works by this author on:Frank Espersen;Frank EspersenStatens Seruminstitut, Department of Clinical Microbiology at Rigshospitalet, Copenhagen, DenmarkSearch for other works by this author on:Arsalan KharazmiArsalan KharazmiStatens Seruminstitut, Department of Clinical Microbiology at Rigshospitalet, Copenhagen, DenmarkSearch for other works by this author on:
-
80 - 84: Immunology of the Chronic Lung InfectionByGerd DöringGerd DöringDepartment of General and Environmental Hygiene Institute, University of Tübingen, FRGSearch for other works by this author on:
-
85 - 93: Inhibition of Normal and Malignant Cell Proliferation by Pyocyanine and 1-Hydroxyphenazine1ByRicardo U. Sorensen;Ricardo U. SorensenaDepartment of Pediatrics, Louisiana State University Medical Center, New Orleans, La.;Search for other works by this author on:David N. Fredricks;David N. FredricksbDepartment of Pediatrics, Case Western Reserve University School of Medicine and Rainbow Babies and Children’s Hospital, Cleveland, Ohio, USASearch for other works by this author on:Robert L. WallerRobert L. WallerbDepartment of Pediatrics, Case Western Reserve University School of Medicine and Rainbow Babies and Children’s Hospital, Cleveland, Ohio, USASearch for other works by this author on:
-
94 - 98: A Review of the Recent Progress in Treatment of Patients with Diffuse Panbronchiolitis Associated with Pseudomonas aeruginosa Infection in JapanByHiroichi TanimotoHiroichi TanimotoDepartment of Internal Medicine IV, Tokyo Jikeikai University School of Medicine, Tokyo, JapanSearch for other works by this author on:
-
99 - 105: The Role of Proteases in Pseudomonas Infections in Burns: A Current HypothesisByIan Alan Holder;Ian Alan HolderShriners Burns Institute, Cincinnati, Ohio, USASearch for other works by this author on:Alice N. NeelyAlice N. NeelyShriners Burns Institute, Cincinnati, Ohio, USASearch for other works by this author on:
-
106 - 114: Analysis of Prognostic Factors in 274 Consecutive Episodes of Pseudomonas aeruginosa Bacteremia1ByJ. Mallolas;J. MallolasInfectious Diseases and Microbiology Units, Hospital Clinic, Faculty of Medicine, Barcelona, SpainSearch for other works by this author on:J. M. Gatell;J. M. GatellInfectious Diseases and Microbiology Units, Hospital Clinic, Faculty of Medicine, Barcelona, SpainSearch for other works by this author on:J. M. Miró;J. M. MiróInfectious Diseases and Microbiology Units, Hospital Clinic, Faculty of Medicine, Barcelona, SpainSearch for other works by this author on:F. Marco;F. MarcoInfectious Diseases and Microbiology Units, Hospital Clinic, Faculty of Medicine, Barcelona, SpainSearch for other works by this author on:J. Bisbe;J. BisbeInfectious Diseases and Microbiology Units, Hospital Clinic, Faculty of Medicine, Barcelona, SpainSearch for other works by this author on:M. T. Jiménez de Anta;M. T. Jiménez de AntaInfectious Diseases and Microbiology Units, Hospital Clinic, Faculty of Medicine, Barcelona, SpainSearch for other works by this author on:E. SorianoE. SorianoInfectious Diseases and Microbiology Units, Hospital Clinic, Faculty of Medicine, Barcelona, SpainSearch for other works by this author on:
-
115 - 119: Defect of Opsonophagocytic Function in Burned Patients: Reversal by Transfusion of Normal Plasma or by Cell Wall-Active AntibioticsByYasuo Ono;Yasuo OnoaTeikyo University, School of Medicine, Tokyo;Search for other works by this author on:Otohiko Kunii;Otohiko KuniiaTeikyo University, School of Medicine, Tokyo;Search for other works by this author on:Shiro KanegasakiShiro KanegasakibInstitute of Medical Science, University of Tokyo, JapanSearch for other works by this author on:
-
120 - 135: Pseudomonas Immunoglobulin Therapy in Patients with Pseudomonas Sepsis and Septic ShockByGünter Pilz;Günter Pilzadepartment of Mediane I, Grosshadern University Hospital, University of Munich, andSearch for other works by this author on:Isolde Class;Isolde ClassbDepartment of Anesthesiology, Marien Hospital, Stuttgart, FRGSearch for other works by this author on:Peter Boeksteger;Peter Boekstegeradepartment of Mediane I, Grosshadern University Hospital, University of Munich, andSearch for other works by this author on:Alexander Pfeifer;Alexander Pfeiferadepartment of Mediane I, Grosshadern University Hospital, University of Munich, andSearch for other works by this author on:Ursula Müller;Ursula Mülleradepartment of Mediane I, Grosshadern University Hospital, University of Munich, andSearch for other works by this author on:Karl WerdanKarl Werdanadepartment of Mediane I, Grosshadern University Hospital, University of Munich, andSearch for other works by this author on:
-
136 - 142: Vaccine Potential of Pseudomonas aeruginosa Mucoid Exopolysaccharide (Alginate)ByGerald B. PierGerald B. PierChanning Laboratory, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass., USASearch for other works by this author on:
-
143 - 156: The First Clinical Trial of Immuno’s Experimental Pseudomonas aeruginosa Flagellar VaccinesByB. A. Crowe;B. A. CroweaMedical Research Center, Immuno AG, Orth, Austria;Search for other works by this author on:O. Enzersberger;O. EnzersbergeraMedical Research Center, Immuno AG, Orth, Austria;Search for other works by this author on:S. Schober-Bendixen;S. Schober-BendixenaMedical Research Center, Immuno AG, Orth, Austria;Search for other works by this author on:A. Mitterer;A. MittereraMedical Research Center, Immuno AG, Orth, Austria;Search for other works by this author on:W. Mundt;W. MundtaMedical Research Center, Immuno AG, Orth, Austria;Search for other works by this author on:I. Livey;I. LiveyaMedical Research Center, Immuno AG, Orth, Austria;Search for other works by this author on:H. Pabst;H. PabstbDepartment of Pediatrics, University of Alberta, Edmonton, Alta., Canada;Search for other works by this author on:R. Kaeser;R. KaesercImmuno Blutplasmazentrum, Mannheim, FRGSearch for other works by this author on:M. Eibl;M. EiblaMedical Research Center, Immuno AG, Orth, Austria;Search for other works by this author on:J. Eibl;J. EiblaMedical Research Center, Immuno AG, Orth, Austria;Search for other works by this author on:F. DornerF. DorneraMedical Research Center, Immuno AG, Orth, Austria;Search for other works by this author on:
-
157 - 162: Clinical Evaluation of an Octavalent Pseudomonas aeruginosa Conjugate Vaccine in Plasma Donors and in Bone Marrow Transplant and Cystic Fibrosis PatientsByS. J. Cryz;S. J. CryzaSwiss Serum and Vaccine Institute, Berne, Switzerland;Search for other works by this author on:E. Fürer;E. FüreraSwiss Serum and Vaccine Institute, Berne, Switzerland;Search for other works by this author on:J. U. Que;J. U. QueaSwiss Serum and Vaccine Institute, Berne, Switzerland;Search for other works by this author on:J. C. Sadoff;J. C. SadoffbWalter Reed Army Institute of Research, Washington, D.C., USA;Search for other works by this author on:M. Brenner;M. BrennercSt. Jude’s Children’s Hospital, Memphis, Tenn., USA;Search for other works by this author on:U. B. SchaadU. B. SchaaddDepartment of Pediatrics, University of Berne, SwitzerlandSearch for other works by this author on:
-
163 - 171: In vitro and in vivo Functional Activities of Monoclonal Antibodies Reactive with Pseudomonas aeruginosa Serogroup 6 Lipopolysaccharides1ByMatthew Pollack;Matthew PollackaDepartment of Medicine, Uniformed Services University of the Health Sciences, F. Edward Hébert School of Medicine, Bethesda, Md., USA;Search for other works by this author on:Misao Tao;Misao TaoaDepartment of Medicine, Uniformed Services University of the Health Sciences, F. Edward Hébert School of Medicine, Bethesda, Md., USA;bDepartment of Internal Medicine, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan;Search for other works by this author on:Moritoshi Akiyama;Moritoshi AkiyamaaDepartment of Medicine, Uniformed Services University of the Health Sciences, F. Edward Hébert School of Medicine, Bethesda, Md., USA;bDepartment of Internal Medicine, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan;Search for other works by this author on:Gerald B. Pier;Gerald B. PiercChanning Laboratory, Department of Medicine, Harvard Medical School, Boston, Mass., USASearch for other works by this author on:Nancy L. KolesNancy L. KolesaDepartment of Medicine, Uniformed Services University of the Health Sciences, F. Edward Hébert School of Medicine, Bethesda, Md., USA;Search for other works by this author on:
-
172 - 184: Broad-Spectra Human Monoclonal Antibodies that Protect Mice Infected with Pseudomonas aeruginosaByHiroshi Noguchi;Hiroshi NoguchiaSumitomo Chemical Co. Ltd, Laboratory of Biotechnology, Takarazuka, Hyogo, andSearch for other works by this author on:Shin-ichi Yokota;Shin-ichi YokotaaSumitomo Chemical Co. Ltd, Laboratory of Biotechnology, Takarazuka, Hyogo, andSearch for other works by this author on:Hiroshi Ohtsuka;Hiroshi OhtsukaaSumitomo Chemical Co. Ltd, Laboratory of Biotechnology, Takarazuka, Hyogo, andSearch for other works by this author on:Tsuneo Kohzuki;Tsuneo KohzukibSumitomo Pharmaceuticals Co. Ltd, Research Laboratories, Osaka, JapanSearch for other works by this author on:Masazumi Terashima;Masazumi TerashimabSumitomo Pharmaceuticals Co. Ltd, Research Laboratories, Osaka, JapanSearch for other works by this author on:Kenji IrieKenji IriebSumitomo Pharmaceuticals Co. Ltd, Research Laboratories, Osaka, JapanSearch for other works by this author on:
-
185 - 195: Therapy of Established Experimental Pseudomonas aeruginosa Infections with Oral Ciprofloxacin and Five Human Monoclonal Antibodies against Lipopolysaccharide AntigensByM. S. Collins;M. S. CollinsPreclinical Microbiology and Immunology, Cutter Biological, Division of Miles Inc., Berkeley, Calif., USASearch for other works by this author on:D. Ladehoff;D. LadehoffPreclinical Microbiology and Immunology, Cutter Biological, Division of Miles Inc., Berkeley, Calif., USASearch for other works by this author on:N. S. MehtonN. S. MehtonPreclinical Microbiology and Immunology, Cutter Biological, Division of Miles Inc., Berkeley, Calif., USASearch for other works by this author on:
-
196 - 202: Protective Effect of Cytokines in Mice to Pseudomonas aeruginosa InfectionByMasayasu Nakano;Masayasu NakanoaDepartment of Microbiology andSearch for other works by this author on:Kazuyasu Onozuka;Kazuyasu OnozukaaDepartment of Microbiology andSearch for other works by this author on:Ken-ichi Sakamoto;Ken-ichi SakamotobOhmiya Medical Center, Jichi Medical School, Tochigi, JapanSearch for other works by this author on:Yasunobu Nakano;Yasunobu NakanoaDepartment of Microbiology andSearch for other works by this author on:Hiroto Shinomiya;Hiroto ShinomiyaaDepartment of Microbiology andSearch for other works by this author on:Tatsuo Saito-TakiTatsuo Saito-TakiaDepartment of Microbiology andSearch for other works by this author on:
-
203 - 208: Enhancement of Nonspecific Resistance against Microbial Infections with Special Reference to Pseudomonas aeruginosa Infection by Chemically Synthesized Lipid A-Subunit AnalogsByM. Matsuura;M. MatsuuraThe Kitasato Institute, Tokyo, JapanSearch for other works by this author on:J. Y. HommaJ. Y. HommaThe Kitasato Institute, Tokyo, JapanSearch for other works by this author on:
-
209 - 214: Drug Resistance of Pseudomonas aeruginosa with Special Reference to New QuinolonesByS. Iyobe;S. IyobeaDepartment of Microbiology, Gunma University School of Medicine;Search for other works by this author on:K. Hirai;K. HiraibCentral Research Laboratories, Kyorin Pharmaceutical Co. Ltd, Tochigi, JapanSearch for other works by this author on:H. HashimotoH. HashimotoaDepartment of Microbiology, Gunma University School of Medicine;Search for other works by this author on:
-
215 - 220: β-Lactamases of Pseudomonas aeruginosaByD. M. LivermoreD. M. LivermoreDepartment of Medical Microbiology, The London Hospital Medical College, London, UKSearch for other works by this author on:
-
221 - 239: Clinical Perspectives of Quinolone Resistance in Pseudomonas aeruginosaByA. DalhoffA. DalhoffBayer AG, Pharma Research Center, Wuppertal, FRGSearch for other works by this author on:
-
240 - 244: Imipenem Resistance in Pseudomonas aeruginosaByJ. P. Quinn;J. P. QuinnaDivision of Infectious Diseases, Michael Reese Hospital, Chicago, Ill.;Search for other works by this author on:D. Miyashiro;D. MiyashiroaDivision of Infectious Diseases, Michael Reese Hospital, Chicago, Ill.;Search for other works by this author on:A. Darzins;A. DarzinsbMicrobiology Department, Ohio State University, Columbus, Ohio;Search for other works by this author on:R. MillerR. MillercBiochemistry Department, Loyola University, Maywood, Ill., USASearch for other works by this author on: